中文
※Source: MOPS (Market Observation Post System)
7827 HanchorBio Inc.
TWSE-listed company
Biotechnology and Medical Care
tib highlight
Stock Price
Company Data
Company Info
| Industry | Biotechnology and Medical Care |
|---|---|
| Capital (TWD) | 1,399,722,620 |
| IR Contact | HUNG, YU-JIUH Investor Relations Director |
| StakeholderAreaURL | https://reurl.cc/R9dR7Z |
| Company Website | https://www.hanchorbio.com |
Financial
EPS
-2.1
2026Q1
P/E Ratio
-
2026/08/13
Monthly Revenue
18,120
2026/7 (Unit: 1,000 TWD)
P/B Ratio
48.33
2026/08/13
Div. Yield
0%
2026/08/13
ROE
-71.16%
2025
ROA
-45.43%
2025
Gross Margin
0%
2026Q1
ESG Info
Material Information
Investor Conference Info
Next Investor Conference
No data available
Recent Investor Conference
2026/05/11 14:30
Add
本公司於上市前辦理股票創新板初次上市前業績發表會，本次業績發表會將由公司經營團隊說明產業發展、財務業務狀況、未來風險、公司治理及企業社會責任、臺灣證券交易所股份有限公司董事會暨上市審議委員會要求補充揭露事項
Power UpTW Program
Listed companies should formulate and disclose operating strategies and business plans, clarify specific measures to enhance corporate value, report to the board of directors, and actively communicate with shareholders.
Annual Report
Financial Report
Financial Information
Revenue Trend
Key Financial Indicators
Financial Ratios
| Year | Period | Status | Board Date | Meeting Date | Cash Dividend | Stock Dividend |
|---|---|---|---|---|---|---|
| 2025 | 114年 年度 | 董事會擬議 | 115/03/25 | 115/05/21 | - | - |
| 2024 | 113年 年度 | 股東會確認 | 114/02/10 | 114/04/20 | - | - |
No warrant data available
| Date | Foreign Net | Trust Net | Dealer Net | Total |
|---|---|---|---|---|
| 2026/08/13 | -5,840 | 0 | 2,127 | -3,713 |
| 2026/08/12 | 71,023 | 0 | 74 | 71,097 |
| 2026/08/11 | 68,000 | 0 | 0 | 68,000 |
| 2026/08/10 | 145,388 | 0 | 119 | 145,507 |
| 2026/08/07 | 95,000 | 0 | -5,445 | 89,555 |
| 2026/08/06 | 140,000 | 0 | -1,963 | 138,037 |
| 2026/08/05 | 70,090 | 0 | 4,036 | 74,126 |
| 2026/08/04 | -2,000 | 0 | -4,850 | -6,850 |
| 2026/08/03 | 54,000 | 0 | -8,384 | 45,616 |
| 2026/07/31 | 46,880 | 0 | -6,000 | 40,880 |
| 2026/07/30 | 112,027 | 0 | -24,368 | 87,659 |
| 2026/07/29 | 210,319 | 0 | 335 | 210,654 |
| 2026/07/28 | 86,050 | 0 | 22,312 | 108,362 |
| 2026/07/27 | 125,500 | 0 | -6,007 | 119,493 |
| 2026/07/24 | 75,000 | 0 | 4,965 | 79,965 |
| 2026/07/23 | -37,000 | 0 | -1,478 | -38,478 |
| 2026/07/22 | -59,148 | 0 | -8,371 | -67,519 |
| 2026/07/21 | -2,000 | 0 | -6,401 | -8,401 |
| 2026/07/20 | -40,700 | 0 | 1,935 | -38,765 |
| 2026/07/17 | -78,781 | 0 | 11,224 | -67,557 |
No margin balance data available
| Event Date | Subsidiary Name | Main Business | Region |
|---|---|---|---|
| 2025/06/20 | 漢康生技股份有限公司 | 生技研發及生技藥品之委託研究 | Taiwan/台灣 |
| 2025/06/20 | FBD Biologics Limited | 生技研發及投資管理 | HONG KONG/香港 |
